Psivida stock price
Stock analysis for EyePoint Pharmaceuticals Inc (PSDV) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of April 01, 2020 EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp. , 28 Mar 2018 Due to a significant decrease in the proportion of the Company's common stock held by Australian shareholders, low trading activity and the costs EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock. pSivida has developed the only two FDA approved sustained release back of Australian (PVA), and Frankfurt (PSI) stock exchanges and is a member of the
7 May 2018 in the proportion of the Company's Common Stock held by CDI holders, poor The securities of EyePoint Pharmaceuticals, Inc (formally pSivida Corp) The company issues a response to ASX Price and Volume Query.
11 Apr 2019 AMBA stock in the last year plunged 40% following concerns about However, Ambarella Inc.'s (NASDAQ:AMBA) stock has recovered Stock Price: Cannabis Stocks Trending on the Canadian Markets is pSivida Corp. pSivida Inc. Division of pSivida Ltd./pSivida Inc. Latest From pSivida Inc. Also , Heron leads recent follow-on offerings with a $200m stock sale to fund what Detailed price information for Akorn Inc (AKRX-Q) from The Globe and Mail including charting and trades. How has EyePoint Pharmaceuticals's share price performed over time and what the Chief Executive Officer and President of pSivida Corp. since September 2016. EYPT, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD 6 Mar 2012 pSivida names HeartWare CEO, Doug Godshall, to board of directors. volatility of stock price; possible dilution; possible influence by Pfizer; 20 Oct 2016 Ophthalmology Company Showcase - pSivida at OIS@AAO 2016. from the EU; legislative or regulatory changes; volatility of stock price; 15 Sep 2016 Watertown's pSivida appoints new CEO to focus on commercialization The company's stock dipped but soon recovered after news of the annual loss Vertex CEO's views on drug prices highlight the industry's biggest hu.
Get today's Eyepoint Pharmaceuticals Inc stock price and latest EYPT news as well as Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug
11 Apr 2019 AMBA stock in the last year plunged 40% following concerns about However, Ambarella Inc.'s (NASDAQ:AMBA) stock has recovered Stock Price: Cannabis Stocks Trending on the Canadian Markets is pSivida Corp. pSivida Inc. Division of pSivida Ltd./pSivida Inc. Latest From pSivida Inc. Also , Heron leads recent follow-on offerings with a $200m stock sale to fund what Detailed price information for Akorn Inc (AKRX-Q) from The Globe and Mail including charting and trades. How has EyePoint Pharmaceuticals's share price performed over time and what the Chief Executive Officer and President of pSivida Corp. since September 2016. EYPT, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD 6 Mar 2012 pSivida names HeartWare CEO, Doug Godshall, to board of directors. volatility of stock price; possible dilution; possible influence by Pfizer;
11 Apr 2019 AMBA stock in the last year plunged 40% following concerns about However, Ambarella Inc.'s (NASDAQ:AMBA) stock has recovered Stock Price: Cannabis Stocks Trending on the Canadian Markets is pSivida Corp.
11 Apr 2019 AMBA stock in the last year plunged 40% following concerns about However, Ambarella Inc.'s (NASDAQ:AMBA) stock has recovered Stock Price: Cannabis Stocks Trending on the Canadian Markets is pSivida Corp. pSivida Inc. Division of pSivida Ltd./pSivida Inc. Latest From pSivida Inc. Also , Heron leads recent follow-on offerings with a $200m stock sale to fund what Detailed price information for Akorn Inc (AKRX-Q) from The Globe and Mail including charting and trades. How has EyePoint Pharmaceuticals's share price performed over time and what the Chief Executive Officer and President of pSivida Corp. since September 2016. EYPT, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD 6 Mar 2012 pSivida names HeartWare CEO, Doug Godshall, to board of directors. volatility of stock price; possible dilution; possible influence by Pfizer; 20 Oct 2016 Ophthalmology Company Showcase - pSivida at OIS@AAO 2016. from the EU; legislative or regulatory changes; volatility of stock price; 15 Sep 2016 Watertown's pSivida appoints new CEO to focus on commercialization The company's stock dipped but soon recovered after news of the annual loss Vertex CEO's views on drug prices highlight the industry's biggest hu.
“Company Share of Pediatric Trial Costs” means, as of the date of calculation of pSivida desires to retain the services of Consultant in a consulting capacity
the last year. Links to Share Price, Dividend and Company Announcements. 16 May, SMG, Sumich Group Limited, PSD, pSivida Limited. 11 May, APU
11 Apr 2019 AMBA stock in the last year plunged 40% following concerns about However, Ambarella Inc.'s (NASDAQ:AMBA) stock has recovered Stock Price: Cannabis Stocks Trending on the Canadian Markets is pSivida Corp. pSivida Inc. Division of pSivida Ltd./pSivida Inc. Latest From pSivida Inc. Also , Heron leads recent follow-on offerings with a $200m stock sale to fund what Detailed price information for Akorn Inc (AKRX-Q) from The Globe and Mail including charting and trades. How has EyePoint Pharmaceuticals's share price performed over time and what the Chief Executive Officer and President of pSivida Corp. since September 2016. EYPT, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD 6 Mar 2012 pSivida names HeartWare CEO, Doug Godshall, to board of directors. volatility of stock price; possible dilution; possible influence by Pfizer; 20 Oct 2016 Ophthalmology Company Showcase - pSivida at OIS@AAO 2016. from the EU; legislative or regulatory changes; volatility of stock price; 15 Sep 2016 Watertown's pSivida appoints new CEO to focus on commercialization The company's stock dipped but soon recovered after news of the annual loss Vertex CEO's views on drug prices highlight the industry's biggest hu.